Measuring the effects of therapy in Parkinson disease.
Shults
Clifford W
CW
Haas
Richard
R
Oakes
David
D
Kieburtz
Karl
K
Plumb
Sandra
S
Shoulson
Ira
I
Beal
M Flint
MF
Juncos
Jorge
J
Nutt
John
J
D000975:Antioxidants / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003067:Coenzymes; D006801:Humans; D009460:Neurologic Examination; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000975:Antioxidants; D000978:Antiparkinson Agents; D003067:Coenzymes; D018696:Neuroprotective Agents; D014451:Ubiquinone; C024989:coenzyme Q10